FOIA request to the Food and Drug Administration seeking records memorializing communications between Commissioner Stephen Hahn and White House Chief of Staff Mark Meadows from Dec.10th and 11th, 2020, in response to reporting that Meadows demanded HahnÕs resignation if FDA did not approve PfizerÕs COVID-19 vaccine by Dec. 11, 2020.

Documents recently obtained by American Oversight add further color to reports of private individuals and groups — some with ties to the president — being granted privileged access to propose pandemic actions.

We’re calling on the CDC and HHS to ensure the email is recovered, as required by federal law.

American Oversight letter to the National Archives and Records Administration, the Department of Health and Human Services, and the Centers for Disease Control and Prevention requesting immediate action to ensure that federal records within the custody of CDC leadership are appropriately preserved or recovered. American Oversight submitted this letter in light of news reports that Redfield allegedly instructed staff to delete an email from a Trump political appointee concerning official government business.

FOIA request to the Centers for Disease Control and Prevention seeking an email mentioned by Dr. Charlotte Kent in a congressional interview, which she said was directed to have been deleted by CDC Director Robert Redfield.

FOIA request to the Centers for Disease Control and Prevention seeking all records reflecting directives from senior officials regarding the deletion or destruction of agency records.

FOIA request to the Centers for Disease Control and Prevention seeking sent email communications and text messages from Director Redfield and Chief of Staff Witkofsky.

The past nine months have seen their share of difficult, frustrating, and even infuriating news. But the past week has aptly captured the administration’s failure to control the pandemic, and the tragic results of that failure, as few previous weeks have.

The lawsuit was filed the same week as news outlets reported that over the summer the administration turned down an offer from Pfizer to purchase additional doses of its vaccine.